3-Hour FDA Audit Preparation Virtual Seminar - PowerPoint PPT Presentation

About This Presentation
Title:

3-Hour FDA Audit Preparation Virtual Seminar

Description:

This seminar is broken into two phases. Phase one corresponding to Day 1 will build basic knowledge of the inspection – the who, what, and when. Phase Two will delve into the how of the inspection from the perspectives of the FDA and those being inspected. We will complete the seminar by discussing how to handle, in the moment, adverse findings as they are identified by the inspector so as to not compound the issues and severity of the findings. – PowerPoint PPT presentation

Number of Views:2
Date added: 5 September 2024
Slides: 28
Provided by: confpanel5
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: 3-Hour FDA Audit Preparation Virtual Seminar


1
FDA Audit, Preparation, Inspection, ConductDos
and Donts
By Speaker
Charles H. Paul, President C. H. Paul Consulting,
Inc.
2024 C. H. Paul Consulting Inc. All rights
reserved
2
Topics
  • Inspection basics
  • Types of inspections
  • Consequences of non-compliance
  • Why does the FDA inspect?
  • Who does the FDA inspect?
  • Good Manufacturing Practices
  • Who are the inspectors and how do they work.
  • Investigation reference documents
  • How to prepare for an FDA inspection
  • Quality System Inspection Readiness
  • Records and documents
  • CAPA and the FDA inspection
  • Inspection prep for CAPA
  • Data integrity
  • The inspection process
  • Personal behaviors during the inspection

3
FDA Inspections Introduction
  • The Food and Drug Administration (FDA) plays a
    pivotal role in safeguarding public health by
    regulating various sectors within the life
    sciences industries.
  • Central to its regulatory framework is the
    practice of conducting inspections.
  • Inspections serve as a crucial mechanism for
    ensuring compliance with regulatory standards and
    Good Manufacturing Practices (GMP).
  • FDA inspections are unannounced and encompass a
    comprehensive review of all aspects of
    production.
  • During inspections, FDA investigators
    meticulously evaluate facilities' adherence to
    regulations.
  • By scrutinizing critical components, the FDA aims
    to identify any deviations or deficiencies.

4
Types of Inspections
  • Pre-Approval Inspections (PAIs)
  • Post Approval Inspections
  • Routine Surveillance Inspections
  • For-Cause or Compliance Follow-Up Inspections
  • Post-Market Inspections
  • Import Inspections

5
Difference between Post Approval, Post Market,
and Surveillance Inspections
  • Post-Approval FDA Inspection Occurs after a
    product has received regulatory approval or
    clearance
  • Post-Market Inspection Conducted after a product
    has been approved or cleared for marketing
    Routine
  • Surveillance Inspection Conducted periodically
    or as needed to assess compliance with regulatory
    requirements.

6
Inspection Overview
  • Initiated without prior notice,
  • FDA inspections are conducted by trained
    investigators
  • Manufacturing facilities, laboratories, and
    processes are examined.
  • These inspections may be routine or conducted in
    response to complaints, adverse events, or
    emerging safety concerns.
  • Investigators employ a systematic approach to
    evaluate facilities' adherence to Good
    Manufacturing Practices (GMP) and other
    regulations.
  • Reviewing critical documentation such as standard
    operating procedures.
  • Investigators assess the physical infrastructure
    of facilities.

7
What Is The Difference Between Inspections?
  • Pharmaceutical inspections
  • Biotechnology inspections
  • Medical device inspections
  • Combination product inspections

8
What is a Warning Letter?
  • The issuance of a warning letter represents a
    formal notice from the FDA to the recipient that
    corrective actions are required.
  • Warning letters are considered public documents
    and are typically posted on the FDA's website for
    public access.
  • The issuance of a warning letter may have
    significant implications for the recipient,
    including reputational damage, increased
    regulatory scrutiny, and potential legal
    liabilities.

9
Why Is Sound Inspection Preparation Important?
  • Regulatory Compliance standards during
    inspections.
  • Risk Mitigation
  • Reputation Management
  • Product Quality and Safety
  • Business Continuity
  • Continuous Improvement

10
Critical Inspection Mistakes
  • Inadequate Documentation
  • Poor Record-Keeping Practices
  • Non-Compliance with GMPs/QSRs
  • Lack of Adequate Training
  • Insufficient Risk Management
  • Ineffective CAPA Processes
  • Poor Communication with FDA Inspectors
  • Failure to Implement Lessons Learned

11
Best Practices Do the right Things Right
  • Preparation
  • Have adequately trained staff with relevant
    expertise and accountability.
  • Obtain upper management support
  • Utilize and value independent regulatory
    compliance and quality assurance teams
  • Ensure the commitments made from previous
    inspections have been implemented
  • Understand your potential quality data sources so
    information can be quickly and easily sourced as
    required
  • Implement and assess an effective quality system
  • Ensure there is a designated company Inspection
    Team
  • Ensure all proper documentation and records are
    up-to-date
  • Maintain effective Management Review and CAPA
    systems.
  • Identify true root causes of issues using
    appropriate problem-solving tools.
  • Understand when a product, or quality issue is
    significant.
  • Have defined metric systems to monitor your
    quality system in order to identify trends, gaps,
    and opportunities

12
What is the Regulatory Expectation?
  • What is the implied documentation expectation?
  • That documents are complete provide all
    necessary information
  • Clear easily understood
  • Visual
  • Flawlessly written
  • Accurate - timely
  • Provide sufficient information for users to
    exactly perform the task in the case of WIs or
    exhibit the behavior in the case of other
    general/policy SOPs
  • Are consistently followed management element
  • Controlled and secure
  • Easily revised as requirements change
  • Training element

13
What is CAPA?
  • Corrective and Preventive Actions. It is a
    systematic approach used by organizations to
    identify, investigate, and address
    non-conformities, quality issues, and potential
    risks.
  • The purpose of CAPA is
  • Corrective actions focus on addressing an
    existing issue or non-conformance, aiming to
    eliminate the root cause, mitigate immediate
    risks, and restore compliance.
  • Preventive actions are proactive measures
    implemented to prevent the recurrence of similar
    issues or potential problems in the future.

14
Preparation Steps
  • Understand Regulatory Requirements
  • Review and Update CAPA Procedures
  • Conduct Internal Audits
  • Train Personnel
  • Perform Mock Inspections
  • Document and Organize CAPA Records
  • Conduct CAPA System Review
  • Stay Updated on Regulatory Changes
  • Maintain a Culture of Compliance

15
What is Data Integrity?
  • Data integrity refers to the accuracy,
    reliability, and consistency of data
  • It is a fundamental aspect of regulatory
    compliance
  • Data integrity encompasses various principles,
    practices, and controls

16
Elements of Data Integrity
  • Accuracy
  • Completeness
  • Consistency
  • Validity
  • Timeliness
  • Security
  • Traceability

17
Common Data Integrity Violations
  • Failure to maintain complete data derived from
    all laboratory tests conducted to ensure
    compliance with established API specifications
    and standards
  • Failure to prevent unauthorized access or changes
    to data, and failure to provide adequate controls
    to prevent omission of data
  • Failure to record activities at the time they are
    performed and destruction of original records.
  • Failure to train employees on their particular
    operations and related GMP practices.

18
Common Data Integrity Errors
  • Incomplete Data
  • Data Falsification
  • Data Entry Errors
  • Data Overwriting
  • Data Duplication
  • Data Loss or Corruption
  • Lack of Data Traceability
  • Non-Compliant Electronic Records
  • Poor Data Management Practices
  • Insufficient Training and Oversight

19
Documents that Cannot be Reviewed
  • Audit reports
  • Financial records and documents
  • Research data/protocols
  • Personnel records
  • Management meeting minutes

20
Exit Process
  • Inspector will present a written FDA form (FDA
    483) if necessary
  • Company should take extensive notes and make sure
    everyone understands the issues
  • Any response to a 483 observation by the company
    should be brief
  • If issue remains unresolved, request that the
    inspector annotate the FDA 483
  • Note any corrective actions

21
Post Inspection
  • Date of inspection
  • Inspection team members
  • Reasons for response
  • Response to each cited deficiency
  • Description of preventive and corrective action
  • Items still in dispute

22
The Psychology Of Behavior And Communications
  • Trust and Rapport Building
  • Perception and Interpretation
  • Active Listening
  • Emotional Intelligence
  • Assertiveness and Advocacy
  • Conflict Resolution
  • Cultural Sensitivity and Diversity
  • Posture and Nonverbal Communication

23
Behaviors That Must Be Exhibited
  • Professionalism
  • Cooperation
  • Transparency
  • Documentation
  • Attention to Detail
  • Compliance Mindset
  • Timeliness
  • Positive Attitude

24
Doing The Right Thing
  • Always be professional
  • Be dressed properly neat and clean
  • Follow all company cleanliness, movement, and
    dressing requirements
  • Be courteous and polite at all times
  • Correct all errors and miscommunications when
    discovered as soon as possible

25
Doing The Right Things
  • When providing documents do so in a timely manner
  • Have documents available
  • Limit the inspectors access
  • Always review the requested record before
    providing
  • Check that the record is the one asked for
  • Send only the record

26
Dealing With Difficult Inspections and Inspectors
  • Remain Calm and Composed
  • Listen Attentively
  • Clarify Misunderstandings
  • Redirect to Procedure
  • Seek Resolution
  • Invoke Chain of Command
  • Document Interactions
  • Follow Up Appropriately

27
Questions
2024 C. H. Paul Consulting Inc. All rights
reserved
Write a Comment
User Comments (0)
About PowerShow.com